CompletedNCT01923896
D-Cycloserine Added to Behavioral Treatment for Feeding Disorders
About this title
Read the official source — NCT01923896Medication studyAges 18 months–6 yearsUnited StatesMental health
Understand this study
Who was this study for?
Listed age limits: 18 months to 6 years.
- Listed locations
- AtlantaSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateMarch 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 16
- Sponsor
- Emory University
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Months to 6 Years
- Official registry ID
- NCT01923896
- Official title
Show the full official title
Use of D-cycloserine to Facilitate Extinction of Food Aversion in Pediatric Populations
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Atlanta
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Emory University, a university.
Did this study involve medication?
Yes. The study involved medication, including d-cycloserine (DCS) and Placebo.
Who was this study for?
Listed age limits: 18 months to 6 years.
